These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 8621173

  • 1. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
    Yuki N, Hayashi N, Kasahara A, Hagiwara H, Mita E, Ohkawa K, Katayama K, Fusamoto H, Kamada T.
    Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
    [Abstract] [Full Text] [Related]

  • 2. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM, Sheen IS, Liaw YF.
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [Abstract] [Full Text] [Related]

  • 3. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N, Hayashi N, Ohkawa K, Hagiwara H, Oshita M, Katayama K, Sasaki Y, Kasahara A, Fusamoto H, Kamada T.
    Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
    [Abstract] [Full Text] [Related]

  • 4. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM, Sheen IS, Liaw YF.
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [Abstract] [Full Text] [Related]

  • 5. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
    Cerino A, Bissolati M, Cividini A, Nicosia A, Esumi M, Hayashi N, Mizuno K, Slobbe R, Oudshoorn P, Silini E, Asti M, Mondelli MU.
    J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
    [Abstract] [Full Text] [Related]

  • 6. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR, Suzuki T, Aizaky H, Flichman D, Colombatto P, Abate ML, Oliveri F, Matsuura Y, Bonino F, Miyamura T.
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C virus replication and antibody responses toward specific hepatitis C virus proteins.
    Yuki N, Hayashi N, Kasahara A, Hagiwara H, Ohkawa K, Fusamoto H, Kamada T.
    Hepatology; 1994 Jun; 19(6):1360-5. PubMed ID: 7514560
    [Abstract] [Full Text] [Related]

  • 8. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T, Yoshioka K, Okumura A, Takayanagi M, Iwata K, Ishikawa T, Kakumu S.
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [Abstract] [Full Text] [Related]

  • 9. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N, Carletti S, Perotti M, Romanò L, Craxì RD, Craxì A, Zanetti AR, Clementi M, Burioni R.
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [Abstract] [Full Text] [Related]

  • 10. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
    Hadlock KG, Gish R, Rowe J, Rajyaguru SS, Newsom M, Warford A, Foung SK.
    J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
    [Abstract] [Full Text] [Related]

  • 11. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.
    Ishii K, Rosa D, Watanabe Y, Katayama T, Harada H, Wyatt C, Kiyosawa K, Aizaki H, Matsuura Y, Houghton M, Abrignani S, Miyamura T.
    Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251
    [Abstract] [Full Text] [Related]

  • 12. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J.
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [Abstract] [Full Text] [Related]

  • 13. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
    Zeuzem S, Franke A, Lee JH, Herrmann G, Ruster B, Roth WK.
    Hepatology; 1996 Nov; 24(5):1003-9. PubMed ID: 8903367
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis.
    Kao JH, Lai MY, Chen PJ, Hwang LH, Chen W, Chen DS.
    Am J Gastroenterol; 1996 Mar; 91(3):506-10. PubMed ID: 8633499
    [Abstract] [Full Text] [Related]

  • 15. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
    Hassoba HM, Terrault NA, el-Gohary AM, Scheffel C, Jou C, Brackett J, Hunt J, Lou SC, Wright TL.
    J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
    Hanuka N, Sikuler E, Tovbin D, Neville L, Nussbaum O, Mostoslavsky M, Orgel M, Yaari A, Manor S, Dagan S, Hilzenrat N, Shemer-Avni Y.
    J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests.
    Fong TL, Lee SR, Briggs WK, Valinluck B, Govindarajan S, Hoffman A, Jaczko B, Redeker AG.
    J Med Virol; 1996 Jul; 49(3):253-8. PubMed ID: 8818974
    [Abstract] [Full Text] [Related]

  • 18. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
    Arnold JC, Töx U, Goeser T, Otto G, Müller HM, Hofmann WJ, Stremmel W, Theilmann L.
    Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
    [Abstract] [Full Text] [Related]

  • 19. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
    León P, López JA, Elola C, Domingo CJ, Echevarria JM.
    Vox Sang; 1996 Apr; 70(4):213-6. PubMed ID: 9123926
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 Apr; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.